Bio-Rad Laboratories Inc (BIO)
287.98
+2.36
(+0.83%)
USD |
NYSE |
Jun 21, 16:00
288.08
+0.10
(+0.03%)
Pre-Market: 20:00
Bio-Rad Laboratories Research and Development Expense (TTM): 238.85M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 238.85M |
December 31, 2023 | 247.43M |
September 30, 2023 | 249.73M |
June 30, 2023 | 273.00M |
March 31, 2023 | 272.30M |
December 31, 2022 | 256.89M |
September 30, 2022 | 249.54M |
June 30, 2022 | 247.22M |
March 31, 2022 | 246.26M |
December 31, 2021 | 260.64M |
September 30, 2021 | 258.71M |
June 30, 2021 | 253.78M |
March 31, 2021 | 242.37M |
December 31, 2020 | 217.76M |
September 30, 2020 | 217.90M |
June 30, 2020 | 206.30M |
March 31, 2020 | 204.44M |
December 31, 2019 | 202.71M |
September 30, 2019 | 198.72M |
June 30, 2019 | 200.02M |
March 31, 2019 | 197.34M |
December 31, 2018 | 199.20M |
September 30, 2018 | 222.16M |
June 30, 2018 | 235.00M |
March 31, 2018 | 250.13M |
Date | Value |
---|---|
December 31, 2017 | 250.16M |
September 30, 2017 | 231.50M |
June 30, 2017 | 219.35M |
March 31, 2017 | 206.57M |
December 31, 2016 | 205.71M |
September 30, 2016 | 204.21M |
June 30, 2016 | 197.62M |
March 31, 2016 | 194.36M |
December 31, 2015 | 192.97M |
September 30, 2015 | 196.37M |
June 30, 2015 | 205.82M |
March 31, 2015 | 214.99M |
December 31, 2014 | 220.33M |
September 30, 2014 | 216.89M |
June 30, 2014 | 217.03M |
March 31, 2014 | 213.15M |
December 31, 2013 | 210.95M |
September 30, 2013 | 213.67M |
June 30, 2013 | 208.55M |
March 31, 2013 | 209.04M |
December 31, 2012 | 211.62M |
September 30, 2012 | 194.33M |
June 30, 2012 | 191.92M |
March 31, 2012 | 187.80M |
December 31, 2011 | 177.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
198.72M
Minimum
Sep 2019
273.00M
Maximum
Jun 2023
237.23M
Average
246.74M
Median
Research and Development Expense (TTM) Benchmarks
Agilent Technologies Inc | 473.00M |
Bruker Corp | 307.60M |
Azenta Inc | 35.10M |
Harvard Bioscience Inc | 11.75M |
Bionano Genomics Inc | 49.88M |